A 9-amino-acid cyclic neuropeptide produced in the hypothalamus. Essential for labor contractions, milk ejection, social bonding, and trust. One of the oldest known peptide hormones and one of the first to be chemically synthesized.
Oxytocin is a 9-amino-acid cyclic peptide hormone produced by magnocellular neurons in the paraventricular and supraoptic nuclei of the hypothalamus and released from the posterior pituitary gland. It was the first peptide hormone to be sequenced and synthesized — Vincent du Vigneaud won the 1955 Nobel Prize in Chemistry for this achievement.
Oxytocin plays dual roles as both a hormone (acting on distant target tissues like the uterus and mammary glands) and a neurotransmitter (modulating social behavior, trust, empathy, and pair bonding in the brain). Its name comes from the Greek 'oxys' (swift) and 'tokos' (childbirth).
Oxytocin binds to the oxytocin receptor (OXTR), a Gq-coupled GPCR. Activation triggers the phospholipase C pathway: PLC cleaves PIP2 into IP3 and DAG. IP3 causes calcium release from the sarcoplasmic reticulum, and the resulting Ca²⁺ spike triggers smooth muscle contraction in the uterus (labor) and myoepithelial cells in the breast (milk ejection).
| Pathway | Effect | Significance |
|---|---|---|
| Uterine contraction | Increases frequency and force of contractions via Ca²⁺ signaling | Essential for labor and delivery |
| Milk ejection | Contracts myoepithelial cells around mammary alveoli | Let-down reflex for breastfeeding |
| Social bonding | CNS effects via OXT receptors in amygdala, nucleus accumbens | Promotes trust, empathy, pair bonding, parental behavior |
| Anxiolytic | Reduces amygdala activation in response to fearful stimuli | Potential therapeutic for anxiety and PTSD |
| Wound healing | Promotes fibroblast migration and anti-inflammatory effects | Accelerates wound closure in animal models |
| Study | Design | Findings | Level |
|---|---|---|---|
| Labor induction | Standard of care, millions of uses | Synthetic oxytocin (Pitocin) reliably induces and augments labor contractions | Level I |
| Postpartum hemorrhage | RCTs, WHO guidelines | First-line treatment for preventing and treating postpartum bleeding | Level I |
| Autism (intranasal) | Multiple RCTs, mixed results | Some studies show improved social cognition; others show no benefit. Results inconsistent | Level I-II (mixed) |
| Social trust | Behavioral studies, n=various | Intranasal oxytocin increased trust in economic games and social interactions | Level II-III |
Labor complications: Excessive oxytocin can cause uterine hyperstimulation, fetal distress, and uterine rupture. Must be carefully titrated with continuous fetal monitoring.
Water intoxication: Oxytocin has antidiuretic effects at high doses. Prolonged IV infusion can cause hyponatremia (low sodium) and seizures.
Intranasal safety: Generally well-tolerated for short-term use. Long-term effects of exogenous oxytocin on social behavior are unknown.
| Jurisdiction | Status |
|---|---|
| FDA | Approved: Pitocin (IV/IM for labor induction, postpartum hemorrhage). Syntocinon nasal spray (milk ejection). |
| WHO | Essential Medicine for labor management |
| WADA | Not banned |